UBS O'Connor’s Eli Lilly LLY Stock Holding History

UBS O'Connor’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,600	Closed	-$1.49M	–	182
2022 Q3	$1.49M	Buy	+4,600	New	+$1.46M	0.02%	691

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

UBS O'Connor's LLY Position: Q4 2022 in Review

UBS O'Connor sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 4,600 shares — an estimated $1.49M sold.

UBS O'Connor first reported a position in LLY in Q3 2022 and held it in 1 quarter. The position peaked at $1.49M in Q3 2022. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

UBS O'Connor reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 4,600 Eli Lilly shares in Q4 2022, an estimated $1.49M.
UBS O'Connor first reported a position in Eli Lilly in Q3 2022 and held it in 1 quarter.
UBS O'Connor's Eli Lilly position peaked at $1.49M in Q3 2022.
2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.